Factors such as quality, time to market, and regulatory changes are forcing an evolution to state-of-the-art analytical test methods.
Anita Bate, PhD
Advertisement
Articles by Anita Bate, PhD
Advertisement
Latest Updated Articles
State-of-the-Art vs. Tried and TrustedPublished: September 15th 2005 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report
2
Everything to Know About Cell and Gene Therapy in 2025
3
Biotech Equipment Market to Approach $144B by 2030: Implications for Pharma R&D
4
Strategies for Building Tech Talent in the Biopharma Industry (Part 4)
5
